Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)

Y. Tsuboi; M. Baker; M. L. Hutton; R. J. Uitti; O. Rascol; M. B. Delisle; X. Soulages; J. R. Murrell; B. Ghetti; M. Yasuda; O. Komure; S. Kuno; K. Arima; N. Sunohara; T. Kobayashi; Y. Mizuno; Zbigniew K. Wszolek

doi:10.1212/01.WNL.0000038909.49164.4B

Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)

Y. Tsuboi, M. Baker, M. L. Hutton, R. J. Uitti, O. Rascol, M. B. Delisle, X. Soulages, J. R. Murrell, B. Ghetti, M. Yasuda, O. Komure, S. Kuno, K. Arima, N. Sunohara, T. Kobayashi, Y. Mizuno, Zbigniew K. Wszolek

Neurology

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Abstract

The tau N279K mutation was identified in four separately ascertained families in the United States, Japan, and France and in another recently discovered affected individual in Japan. The authors analyzed genealogical and clinical records and DNA samples. Average age at onset was 43 years; survival time was 7 years. All families exhibited similar clinical features, with parkinsonism, dementia, and supranuclear palsy uniformly seen. A founder effect indicated by a shared disease haplotype was seen only in two Japanese families. The N279K mutation can develop independently in different parts of the world.

Original language	English (US)
Pages (from-to)	1791-1793
Number of pages	3
Journal	Neurology
Volume	59
Issue number	11
DOIs	https://doi.org/10.1212/01.WNL.0000038909.49164.4B
State	Published - Dec 10 2002

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/01.WNL.0000038909.49164.4B

Cite this

Tsuboi, Y., Baker, M., Hutton, M. L., Uitti, R. J., Rascol, O., Delisle, M. B., Soulages, X., Murrell, J. R., Ghetti, B., Yasuda, M., Komure, O., Kuno, S., Arima, K., Sunohara, N., Kobayashi, T., Mizuno, Y., & Wszolek, Z. K. (2002). Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology, 59(11), 1791-1793. https://doi.org/10.1212/01.WNL.0000038909.49164.4B

Tsuboi, Y, Baker, M, Hutton, ML, Uitti, RJ, Rascol, O, Delisle, MB, Soulages, X, Murrell, JR, Ghetti, B, Yasuda, M, Komure, O, Kuno, S, Arima, K, Sunohara, N, Kobayashi, T, Mizuno, Y & Wszolek, ZK 2002, 'Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)', Neurology, vol. 59, no. 11, pp. 1791-1793. https://doi.org/10.1212/01.WNL.0000038909.49164.4B

@article{56d4eb50b5914d938a77aacdd5589bd1,

title = "Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)",

abstract = "The tau N279K mutation was identified in four separately ascertained families in the United States, Japan, and France and in another recently discovered affected individual in Japan. The authors analyzed genealogical and clinical records and DNA samples. Average age at onset was 43 years; survival time was 7 years. All families exhibited similar clinical features, with parkinsonism, dementia, and supranuclear palsy uniformly seen. A founder effect indicated by a shared disease haplotype was seen only in two Japanese families. The N279K mutation can develop independently in different parts of the world.",

author = "Y. Tsuboi and M. Baker and Hutton, {M. L.} and Uitti, {R. J.} and O. Rascol and Delisle, {M. B.} and X. Soulages and Murrell, {J. R.} and B. Ghetti and M. Yasuda and O. Komure and S. Kuno and K. Arima and N. Sunohara and T. Kobayashi and Y. Mizuno and Wszolek, {Zbigniew K.}",

year = "2002",

month = dec,

day = "10",

doi = "10.1212/01.WNL.0000038909.49164.4B",

language = "English (US)",

volume = "59",

pages = "1791--1793",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

TY - JOUR

T1 - Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)

AU - Tsuboi, Y.

AU - Baker, M.

AU - Hutton, M. L.

AU - Uitti, R. J.

AU - Rascol, O.

AU - Delisle, M. B.

AU - Soulages, X.

AU - Murrell, J. R.

AU - Ghetti, B.

AU - Yasuda, M.

AU - Komure, O.

AU - Kuno, S.

AU - Arima, K.

AU - Sunohara, N.

AU - Kobayashi, T.

AU - Mizuno, Y.

AU - Wszolek, Zbigniew K.

PY - 2002/12/10

Y1 - 2002/12/10

N2 - The tau N279K mutation was identified in four separately ascertained families in the United States, Japan, and France and in another recently discovered affected individual in Japan. The authors analyzed genealogical and clinical records and DNA samples. Average age at onset was 43 years; survival time was 7 years. All families exhibited similar clinical features, with parkinsonism, dementia, and supranuclear palsy uniformly seen. A founder effect indicated by a shared disease haplotype was seen only in two Japanese families. The N279K mutation can develop independently in different parts of the world.

AB - The tau N279K mutation was identified in four separately ascertained families in the United States, Japan, and France and in another recently discovered affected individual in Japan. The authors analyzed genealogical and clinical records and DNA samples. Average age at onset was 43 years; survival time was 7 years. All families exhibited similar clinical features, with parkinsonism, dementia, and supranuclear palsy uniformly seen. A founder effect indicated by a shared disease haplotype was seen only in two Japanese families. The N279K mutation can develop independently in different parts of the world.

UR - http://www.scopus.com/inward/record.url?scp=0037058799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037058799&partnerID=8YFLogxK

U2 - 10.1212/01.WNL.0000038909.49164.4B

DO - 10.1212/01.WNL.0000038909.49164.4B

M3 - Article

C2 - 12473774

AN - SCOPUS:0037058799

SN - 0028-3878

VL - 59

SP - 1791

EP - 1793

JO - Neurology

JF - Neurology

IS - 11

ER -

Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this